Skip to content

Pain control in Lower limb traumatic patients

comparison of analgesic effect of memantin plus morphin with morphin in patient with lower limb trauma

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201404107751N3
Enrollment
1000
Registered
2014-11-28
Start date
2014-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain in limb. Pain in limb

Interventions

Intervention 1: first group:morphin+memantin 10 mg. Intervention 2: second group:morphin+memantin 5 mg. Intervention 3: third group:morphin +placebo.
Treatment - Drugs
first group:morphin+memantin 10 mg
second group:morphin+memantin 5 mg
third group:morphin +placebo

Sponsors

Vice chancellor for research, Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Fracture in lower extremity; GCS=15; VAS=6 ; ability to talk; stable hemodynamic. Exclusion Criteria: age>65 and age <18; Opium addiction; Psychological disorder; analgesia administration before admission in Emergency department; chronic therapy with analgesic drugs; sensitivity to morphine or memantin; unable to understand the VAS concept; pregnancy; necessity to nerve block; unwilling to take part in the intervention; refuse to continue the intervention; major trauma which is life threatening or causing defects; any history of chronic liver; kidney; lung; cardiac disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain Severity. Timepoint: 0, 60, 120, 240, 480 and 720 minutes after treatment. Method of measurement: Administration of Visual Analogue Scale and asking the patient to determine the severity of pain.

Secondary

MeasureTime frame
Side effects and changes in vital signs. Timepoint: 30, 60 and 120 minutes after treatment. Method of measurement: Patient monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeid Abbasi, MD

Iran University of Medical Sciences

eshabani1222@yahoo.com+98 21 8825 2024

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026